Thrivent Financial for Lutherans’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$113M Buy
1,252,795
+15,686
+1% +$1.44M 0.22% 99
2025
Q4
$111M Buy
1,237,109
+245,599
+25% +$23.3M 0.2% 106
2025
Q3
$97.7M Buy
991,510
+79,736
+9% +$7.9M 0.19% 114
2025
Q2
$83.2M Buy
911,774
+72,326
+9% +$6.99M 0.18% 137
2025
Q1
$95M Sell
839,448
-13
-0% -$1.39K 0.21% 115
2024
Q4
$88.7M Sell
839,461
-28,859
-3% -$3.1M 0.17% 145
2024
Q3
$93.7M Sell
868,320
-43,324
-5% -$4.73M 0.18% 148
2024
Q2
$98.9M Sell
911,644
-32,660
-3% -$3.85M 0.2% 128
2024
Q1
$125M Buy
944,304
+220,631
+30% +$27.6M 0.25% 95
2023
Q4
$88.1M Buy
723,673
+115,819
+19% +$12.9M 0.19% 143
2023
Q3
$68.2M Buy
607,854
+8,890
+1% +$1.13M 0.16% 173
2023
Q2
$87.2M Sell
598,964
-12,752
-2% -$1.73M 0.2% 141
2023
Q1
$79M Buy
611,716
+1,753
+0.3% +$220K 0.19% 152
2022
Q4
$77.8M Sell
609,963
-16,280
-3% -$1.89M 0.2% 137
2022
Q3
$65.5M Sell
626,243
-57,228
-8% -$6.28M 0.18% 158
2022
Q2
$71.8M Buy
683,471
+174,015
+34% +$20.6M 0.19% 139
2022
Q1
$65.2M Buy
509,456
+7,947
+2% +$958K 0.13% 201
2021
Q4
$61.9M Buy
501,509
+13,678
+3% +$1.79M 0.12% 222
2021
Q3
$69.3M Buy
487,831
+160,156
+49% +$23.6M 0.14% 184
2021
Q2
$51.2M Buy
327,675
+161,003
+97% +$26.1M 0.1% 242
2021
Q1
$25.9M Buy
166,672
+8,003
+5% +$1.24M 0.06% 375
2020
Q4
$23.7M Sell
158,669
-8,727
-5% -$1.23M 0.05% 406
2020
Q3
$22.1M Sell
167,396
-5,261
-3% -$687K 0.06% 376
2020
Q2
$20M Buy
172,657
+1,227
+0.7% +$141K 0.06% 367
2020
Q1
$16.8M Buy
171,430
+160,536
+1,474% +$21M 0.06% 356
2019
Q4
$1.58M Buy
10,894
+1,289
+13% +$178K ﹤0.01% 1171
2019
Q3
$1.28M Buy
9,605
+119
+1% +$15.4K ﹤0.01% 1246
2019
Q2
$1.08M Buy
9,486
+85
+0.9% +$9.96K ﹤0.01% 1347
2019
Q1
$1.17M Buy
9,401
+250
+3% +$28.4K ﹤0.01% 1273
2018
Q4
$921K Buy
9,151
+161
+2% +$18.1K ﹤0.01% 1205
2018
Q3
$1.15M Buy
8,990
+199
+2% +$23.7K ﹤0.01% 1180
2018
Q2
$951K Buy
8,791
+89
+1% +$9.69K ﹤0.01% 1283
2018
Q1
$921K Buy
8,702
+177
+2% +$20.6K ﹤0.01% 1281
2017
Q4
$999K Sell
8,525
-636,053
-99% -$71.9M ﹤0.01% 1256
2017
Q3
$73.3M Sell
644,578
-13,662
-2% -$1.58M 0.26% 90
2017
Q2
$82.1M Buy
658,240
+650,336
+8,228% +$77.1M 0.34% 66
2017
Q1
$934K Buy
7,904
+546
+7% +$61.9K ﹤0.01% 1211
2016
Q4
$737K Buy
7,358
+463
+7% +$49.6K ﹤0.01% 1308
2016
Q3
$870K Buy
6,895
+515
+8% +$63.6K ﹤0.01% 1195
2016
Q2
$746K Buy
6,380
+824
+15% +$93.3K ﹤0.01% 1234
2016
Q1
$576K Buy
5,556
+464
+9% +$44.9K ﹤0.01% 1310
2015
Q4
$507K Sell
5,092
-68,393
-93% -$6.69M ﹤0.01% 1352
2015
Q3
$6.7M Buy
73,485
+68,794
+1,467% +$6.9M 0.04% 439
2015
Q2
$498K Buy
4,691
+206
+5% +$22.8K ﹤0.01% 1123
2015
Q1
$512K Buy
4,485
+206
+5% +$23.5K ﹤0.01% 1102
2014
Q4
$472K Buy
4,279
+52
+1% +$5.48K ﹤0.01% 1145
2014
Q3
$413K Buy
4,227
+158
+4% +$15.5K ﹤0.01% 1200
2014
Q2
$410K Buy
+4,069
New +$397K ﹤0.01% 1222
2013
Q4
Sell
-569,010
Closed -$45.4M 1615
2013
Q3
$45.4M Buy
569,010
+22,567
+4% +$1.78M 0.29% 81
2013
Q2
$39.8K Buy
+546,443
New +$40.9M 0.26% 90

Other funds holding ZBH

Thrivent Financial for Lutherans's ZBH Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its Zimmer Biomet (ZBH) stake by 1.3% in Q1 2026, buying an estimated $1.44M and bringing the position to 1,252,795 shares worth $113M. The position accounts for 0.22% of the portfolio, ranked #99.

Thrivent Financial for Lutherans first reported a position in ZBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $125M in Q1 2024. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Thrivent Financial for Lutherans held 1,252,795 shares of Zimmer Biomet worth $113M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 15,686 Zimmer Biomet shares in Q1 2026, an estimated $1.44M.
  • Zimmer Biomet made up 0.22% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #99 holding.
  • Thrivent Financial for Lutherans first reported a position in Zimmer Biomet in Q2 2013 and has held it in 50 quarters since.
  • Thrivent Financial for Lutherans's Zimmer Biomet position peaked at $125M in Q1 2024.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.